Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Diagnosis by Serge Haan
Introduction
Serge Haan is an accomplished inventor based in Mondercange, Luxembourg. He has made significant contributions to the field of cancer diagnosis through his innovative research and patented methods. His work focuses on improving clinical outcomes for patients diagnosed with various types of cancer.
Latest Patents
Haan holds a patent for "Biomarkers for cancer diagnosis, prediction or staging." This invention relates to a method for predicting clinical outcomes for subjects diagnosed with colorectal cancer, skin cancer, head and neck cancer, or lung cancer. Additionally, it provides a method for predicting whether a subject has a predisposition to develop such cancers, as well as aiding in the staging of these cancers. The methods utilize biomarkers such as MYO5B and/or RAB8A, and may also include RAB9A, RAB10, RAB11A, RAB25, CDC42, RAC, and/or RhoA.
Career Highlights
Throughout his career, Serge Haan has worked with notable institutions, including the University of Luxembourg. His research has focused on the development of innovative methods that enhance cancer diagnosis and treatment.
Collaborations
Haan has collaborated with esteemed colleagues such as Elisabeth Letellier and Martine Schmitz, contributing to advancements in cancer research and diagnostics.
Conclusion
Serge Haan's work in cancer diagnosis exemplifies the impact of innovative research on improving patient outcomes. His patented methods represent a significant step forward in the fight against cancer.